Panel recommends Serum Institute's name for phase 2, 3 human clinical trials of Oxford vaccine candidate

The recommendations of the committee at the Central Drugs Standard
Control Organisation have been sent to the Drugs Controller General of
India for approval.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms

Comments

Popular posts from this blog

Sunday Worship Service

India may soon line up for Putin’s once-scorned vaccine - now a favorite in pandemic fight